Skip to main content
Sign In

Joel C. Marrs, PharmD, MPH, BCACP, BCCP, BCPS-AQ Cardiology, CHC, CLS

Associate Professor, Department of Clinical Pharmacy

Mailing Address:

University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Department of Clinical Pharmacy
Mailstop, C238
12850 E. Montview Blvd., V20-2128
Aurora, CO 80045

Office Location:

Pharmacy and Pharmaceutical Sciences Building (V20)
Second Floor
Room 2128

Contact Information:

Voice: 303-724-5780
Fax: 303-724-0971

Training and Education:

  • Masters of Public Health-Epidemiology, University of Colorado Anschutz Medical Campus, Colorado School of Public Health (2016-2019)
  • Academic Leadership Fellows Program, American Association of Colleges of Pharmacy (AACP), 2018-2019
  • Certificate in Public Health Sciences, University of Colorado Anschutz Medical Campus, Colorado School of Public Health (2014-2016)
  • Patient Centered Outcomes Research (PCOR) Scholars Program, Funded by Agency for Healthcare Research and Quality (AHRQ) grant R24 (2014-2016)
  • American College of Clinical Pharmacy Heart Failure Traineeship (2008)
  • Ambulatory Care Residency (PGY2), University of Colorado Denver (2005-2006)
  • Pharmacy Practice Residency (PGY1), Mount Carmel Medical Center (2004-2005)
  • PharmD, Butler University (2004)


  • American College of Clinical Pharmacy Academy Teaching and Learning Certificate (2009)
  • American Hypertension Specialist Certification Program, Hypertension Certified Hypertension Clinician (CHC, 2016-2026)
  • American Pharmaceutical Association Immunization Provider (2007)
  • Board Certified Ambulatory Care Pharmacist (2013-2020)
  • Board Certified Cardiology Pharmacist (2018-2025)
  • Board Certified Pharmacotherapy Specialist (2005-2012, recertified 2012-2019)
  • Board Certified Pharmacotherapy Specialist with Added Qualifications in Cardiology (2009-2023)
  • Clinical Lipid Specialist and Diplomate of the Accreditation Council for Clinical Lipidology (2008-2018, recertified 2018-2028)


  • Fellow American Heart Association (FAHA, 2017)
  • Fellow American Society of Health-System Pharmacy (FASHP, 2015)
  • Fellow American College of Clinical Pharmacy (FCCP, 2014)
  • Fellow National Lipid Association (FNLA, 2012)

Previous Academic Appointments:

  • Lecturer, University of Colorado Anschutz Medical Campus, Child Health Associate/Physician Assistant Program (2019-present)
  • Lecturer, Oregon Health & Science University Division of Physician Assistant Studies (2007-2018)
  • Clinical Instructor, Oregon Health & Science University School of Medicine (2007-2009)
  • Clinical Assistant Professor, Oregon State University College of Pharmacy (2006-2009)
  • Clinical Instructor, University of Colorado School of Pharmacy (2005-2006)

Teaching Activities:

Dr. Marrs teaches several components of the Entry Level and North American-Trained PharmD programs. He teaches on the topics of primary and secondary prevention of cardiovascular (CV) disease (e.g., CV Anatomy/Physiology/Pathophysiology, Stable Ischemic Heart Disease, Hypertensive Crises, Peripheral Artery Disease, Antiplatelet Pharmacology/Therapy, Anti-ischemic pharmacology, CV Risk Reduction and Assessment, Heart Failure, Advanced Dyslipidemia Management) and comprehensive pharmacotherapy cases. He is one of the directors of the Clinical Capstone Course (PHRD 7995). He precepts University of Colorado post-graduate year 2 (PGY2) ambulatory care pharmacy residents, Denver Health (DH) PGY2 Ambulatory Care pharmacy residents and DH PGY1 pharmacy residents. In addition, he is a preceptor for introductory pharmacy practice experience (IPPE) and advanced pharmacy practice experience (APPE) students.

Clinical Activities:

Dr. Marrs is a Clinical Pharmacy Specialist in Adult Internal Medicine at the Gipson Eastside Family Health Center, one of the Denver Health Community Health Clinics (FQHC). At this clinic site, Dr. Marrs provides pharmacotherapy consultations and patient care visits for hypertension/resistant hypertension, primary/secondary CV disease prevention, diabetes mellitus, anticoagulation, and medication management. In addition, he is the lead clinical pharmacist on population health initiatives for hypertension at DH (e.g., home blood pressure monitoring, ambulatory care blood pressuring monitoring) for patients across the Denver Community Health Clinics. His clinic serves as a rotation site for P3 students, P4 students, PGY1 and PGY2 residents. Dr. Marrs’ areas of interest include optimization of pharmacotherapy for primary/secondary CV disease prevention, diabetes mellitus, and interdisciplinary collaboration to improve patient outcomes (e.g., pharmacist-patient navigator interventions).

Scholarly Activities:

Dr. Marrs participates in research focused on CV pharmacotherapy (e.g., hypertension, dyslipidemia, heart failure, and diabetes mellitus). Recent and ongoing research is in the area of patient centered outcomes research (PCOR), secondary database analyses, and medication adherence focused on hypertension. He has published research, review articles, textbook chapters, and continuing education materials related to these topics. In addition, he enjoys precepting PharmD student honor research projects and PGY1/PGY2 residency research projects.

Professional Service:

Dr. Marrs is a past chair of the Curriculum Committee and is a faculty advisor for the Colorado Student College of Clinical Pharmacy (ACCP student chapter). Dr. Marrs is one of the core faculty for the ASHP Pharmacotherapy and the ACCP/ASHP Ambulatory Care Pharmacist Board Certification review courses. He is the current Chair-elect of the ASHP Section of Clinical Scientists and Specialists (SCSS). In addition, he is a past member of the ASHP Council on Therapeutics and past Chair of the ASHP SCSS Educational Steering Committee. He is a past-chair of the ACCP Adult Medicine Practice & Research Network (PRN) and past chair of the AACP Curriculum Special Interest Group (SIG). He is an active member of the APhA, ASHP, ACCP, and AACP. He has been an active member of the NLA for the last decade. He served as the Secretary, President-elect, and the President in subsequent years for Southwest Lipid Association from 2014 to 2018. He is currently a board member for the NLA and is Co-Chair for the NLA Inter-Professional Continuing Education (ICE) committee and the Early Career Development Committee. Dr. Marrs is an elected member of the Board of Governors for the ACCL. Since 2013 he has served on the National Quality Forum (NQF) Cardiovascular Standing Committee. Dr. Marrs serves as the co-chair of DH CV Disease Working Group, is a member of the Ambulatory Care Clinical Pharmacy Team, a member of the Residency Advisory Committee (RAC) and a member of the Anticoagulation Working Group. Dr. Marrs has co-directed the teaching certificate for pharmacy residents for the past 10 years at the University of Colorado and has a strong professional interest in the expansion of teaching certificate programs/academic training for post-graduate pharmacy residents and fellows.

Colorado Pharmacy Residency Teaching Certificate (CPRTC) Program


  • Academic year 2010-2011: 25 residents completed program
  • Academic year 2011-2012: 38 residents/fellows completed program
  • Academic year 2012-2013: 42 residents/fellows/preceptors completed program
  • Academic year 2013-2014: 44 residents/fellows/preceptors completed program
  • Academic year 2014-2015: 42 residents/fellows/preceptors completed program
  • Academic year 2015-2016: 55 residents/fellows/preceptors completed program
  • Academic year 2016-2017: 55 residents/fellows/preceptors completed program
  • Academic year 2017-2018: 64 residents/fellows/preceptors completed program
  • Academic year 2018-2019: 59 residents/fellows/preceptors completed program
  • Academic year 2019-2020: 58 residents/fellows/preceptors enrolled​

Recent Publications​​